Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of
نویسندگان
چکیده
Robert V. Limet, Gerhard Schuler, Friedrich W. Mohr, Wietze Lindeboom, Amanda G.M.R. Sousa, J. Alexandre Abizaid, Marco A. Costa, Marinella Centemero, Andrea S. Abizaid, Victor M.G. Legrand, Study (ARTS) Trial Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2001 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/hc3101.09370
منابع مشابه
Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial.
BACKGROUND Our aims were to compare coronary artery bypass grafting (CABG) and stenting for the treatment of diabetic patients with multivessel coronary disease enrolled in the Arterial Revascularization Therapy Study (ARTS) trial and to determine the costs of these 2 treatment strategies. METHODS AND RESULTS Patients (n=1205) were randomly assigned to stent implantation (n=600; diabetic, 112...
متن کاملImportance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma.
The choice of which coronary revascularization strategy is best for diabetic patients with multivessel coronary disease has always been complex. The presence of diabetes, especially insulin-requiring diabetes, has been associated with higher rates of acute and late-term adverse events for both PTCA1 and bypass surgery,2 making either approach seemingly suboptimal. The results of the Bypass Angi...
متن کاملInfluence of the Bypass Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on Practice Patterns Results from the National Cardiovascular Network Database
Background—In 1995, the Bypass Angioplasty Revascularization Investigation (BARI) found that patients with diabetes had a survival benefit when treated with surgical revascularization versus balloon angioplasty, prompting a National Heart Lung and Blood Institute (NHLBI) “Clinical Alert.” The influence of the BARI findings and of the Clinical Alert on practice patterns is unknown. Methods and R...
متن کاملTreatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization.
OBJECTIVE We sought to assess determinants of clinical decision making in patients with stable coronary artery disease. METHODS The 2936 patients with stable angina pectoris who enrolled in the Euro Heart Survey on Coronary Revascularization were the subject of this analysis. After the diagnosis has been confirmed, physicians decided on treatment: medical management or revascularization thera...
متن کاملCoronary artery disease and diabetes mellitus.
Diabetes mellitus (DM) is a major risk factor for cardiovascular disease. Near-normal glycemic control does not reduce cardiovascular events. For many patients with 1- or 2-vessel coronary artery disease, there is little benefit from any revascularization procedure over optimal medical therapy. For multivessel coronary disease, randomized trials demonstrated the superiority of coronary artery b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2001